| Year |
Citation |
Score |
| 2023 |
Marquardt V, Theruvath J, Pauck D, Picard D, Qin N, Blümel L, Maue M, Bartl J, Ahmadov U, Langini M, Meyer FD, Cole A, Cruz-Cruz J, Graef CM, Wölfl M, ... ... Cheshier SH, et al. Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation. Journal For Immunotherapy of Cancer. 11. PMID 36639156 DOI: 10.1136/jitc-2022-005871 |
0.507 |
|
| 2020 |
Higgins DMO, Caliva M, Schroeder M, Carlson B, Upadhyayula PS, Milligan BD, Cheshier SH, Weissman IL, Sarkaria JN, Meyer FB, Henley JR. Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas. Bmc Cancer. 20: 1213. PMID 33302912 DOI: 10.1186/s12885-020-07694-4 |
0.569 |
|
| 2020 |
Gardner M, Turner JE, Youssef OA, Cheshier S. In Vitro Macrophage-Mediated Phagocytosis Assay of Brain Tumors. Cureus. 12: e10964. PMID 33209523 DOI: 10.7759/cureus.10964 |
0.41 |
|
| 2020 |
Cole AP, Hoffmeyer E, Chetty SL, Cruz-Cruz J, Hamrick F, Youssef O, Cheshier S, Mitra SS. Microglia in the Brain Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1273: 197-208. PMID 33119883 DOI: 10.1007/978-3-030-49270-0_11 |
0.546 |
|
| 2020 |
Quon JL, Bala W, Chen LC, Wright J, Kim LH, Han M, Shpanskaya K, Lee EH, Tong E, Iv M, Seekins J, Lungren MP, Braun KRM, Poussaint TY, Laughlin S, ... ... Cheshier SH, et al. Deep Learning for Pediatric Posterior Fossa Tumor Detection and Classification: A Multi-Institutional Study. Ajnr. American Journal of Neuroradiology. PMID 32816765 DOI: 10.3174/Ajnr.A6704 |
0.398 |
|
| 2020 |
Theruvath J, Sotillo E, Mount CW, Graef CM, Delaidelli A, Heitzeneder S, Labanieh L, Dhingra S, Leruste A, Majzner RG, Xu P, Mueller S, Yecies DW, Finetti MA, Williamson D, ... ... Cheshier S, et al. Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors. Nature Medicine. PMID 32341579 DOI: 10.1038/S41591-020-0821-8 |
0.575 |
|
| 2020 |
Mondal G, Lee JC, Ravindranathan A, Villanueva-Meyer JE, Tran QT, Allen SJ, Barreto J, Gupta R, Doo P, Van Ziffle J, Onodera C, Devine P, Grenert JP, Samuel D, Li R, ... ... Cheshier S, et al. Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. Acta Neuropathologica. PMID 32303840 DOI: 10.1007/S00401-020-02155-5 |
0.307 |
|
| 2020 |
Cheshier S, Taylor MD, Ayrault O, Mueller S. Introduction. Pediatric brain tumor. Neurosurgical Focus. 48: E1. PMID 31896080 DOI: 10.3171/2019.10.Focus19799 |
0.411 |
|
| 2019 |
Lucas CG, Villanueva-Meyer JE, Whipple N, Oberheim Bush NA, Cooney T, Chang S, McDermott M, Berger M, Cham E, Sun PP, Putnam A, Zhou H, Bollo R, Cheshier S, Poppe MM, et al. Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features. Brain Pathology (Zurich, Switzerland). PMID 31609499 DOI: 10.1111/Bpa.12797 |
0.392 |
|
| 2019 |
Gholamin S, Youssef OA, Rafat M, Esparza R, Kahn S, Shahin M, Giaccia AJ, Graves EE, Weissman I, Mitra S, Cheshier SH. Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma. Innate Immunity. 1753425919876690. PMID 31547758 DOI: 10.1177/1753425919876690 |
0.77 |
|
| 2019 |
SoRelle ED, Yecies DW, Liba O, Bennett FC, Graef CM, Dutta R, Mitra S, Joubert LM, Cheshier S, Grant GA, de la Zerda A. Spatiotemporal Tracking of Brain-Tumor-Associated Myeloid Cells in Vivo through Optical Coherence Tomography with Plasmonic Labeling and Speckle Modulation. Acs Nano. PMID 31259527 DOI: 10.1021/Acsnano.9B02656 |
0.578 |
|
| 2019 |
Mohanty S, Yerneni K, Theruvath JL, Graef CM, Nejadnik H, Lenkov O, Pisani L, Rosenberg J, Mitra S, Cordero AS, Cheshier S, Daldrup-Link HE. Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma. Cell Death & Disease. 10: 36. PMID 30674867 DOI: 10.1038/S41419-018-1285-3 |
0.549 |
|
| 2019 |
Hutter G, Theruvath J, Graef CM, Zhang M, Schoen MK, Manz EM, Bennett ML, Olson A, Azad TD, Sinha R, Chan C, Assad Kahn S, Gholamin S, Wilson C, Grant G, ... ... Cheshier SH, et al. Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 30602457 DOI: 10.1073/Pnas.1721434116 |
0.805 |
|
| 2018 |
Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, ... ... Cheshier SH, et al. Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4651. PMID 30389946 DOI: 10.1038/S41467-018-07182-1 |
0.748 |
|
| 2018 |
Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, ... ... Cheshier SH, et al. Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4121. PMID 30297829 DOI: 10.1038/S41467-018-06564-9 |
0.794 |
|
| 2018 |
Mitra S, Cheshier S. IMMU-14. KICKSTARTING THE CANCER IMMUNITY CYCLE BY INNATE CHECKPOINT INHIBITION TO TARGET PEDIATRIC BRAIN TUMORS Neuro-Oncology. 20: i101-i101. DOI: 10.1093/Neuonc/Noy059.330 |
0.555 |
|
| 2018 |
Theruvath J, Graef C, Heitzeneder S, Majzner R, Mitra S, Cheshier SH, Mackall C. ATRT-25. CHECKPOINT MOLECULE B7-H3 IS HIGHLY EXPRESSED ON ATYPICAL RHABDOID TERATOID TUMOR (ATRT) AND IS A PROMISING CANDIDATE FOR CAR T CELL THERAPY Neuro-Oncology. 20: i33-i33. DOI: 10.1093/Neuonc/Noy059.023 |
0.547 |
|
| 2017 |
Mohanty S, Chen Z, Li K, Morais GR, Klockow J, Yerneni K, Pisani L, Chin FT, Mitra S, Cheshier S, Chang E, Gambhir SS, Rao J, Loadman PM, Falconer RA, et al. A novel theranostic strategy for MMP-14 expressing glioblastomas impacts survival. Molecular Cancer Therapeutics. PMID 28659432 DOI: 10.1158/1535-7163.Mct-17-0022 |
0.408 |
|
| 2017 |
Gholamin S, Mitra SS, Feroze AH, Liu J, Kahn SA, Zhang M, Esparza R, Richard C, Ramaswamy V, Remke M, Volkmer AK, Willingham S, Ponnuswami A, McCarty A, Lovelace P, ... ... Cheshier SH, et al. Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Science Translational Medicine. 9. PMID 28298418 DOI: 10.1126/Scitranslmed.Aaf2968 |
0.818 |
|
| 2017 |
Chang J, Mancuso MR, Maier C, Liang X, Yuki K, Yang L, Kwong JW, Wang J, Rao V, Vallon M, Kosinski C, Zhang JJ, Mah AT, Xu L, Li L, ... ... Cheshier SH, et al. Gpr124 is essential for blood-brain barrier integrity in central nervous system disease. Nature Medicine. PMID 28288111 DOI: 10.1038/Nm.4309 |
0.765 |
|
| 2017 |
Li MD, Forkert ND, Kundu P, Ambler C, Lober RM, Burns TC, Barnes PD, Gibbs IC, Grant GA, Fisher PG, Cheshier SH, Campen CJ, Monje M, Yeom KW. Brain Perfusion and Diffusion Abnormalities in Children Treated for Posterior Fossa Brain Tumors. The Journal of Pediatrics. PMID 28187964 DOI: 10.1016/J.Jpeds.2017.01.019 |
0.348 |
|
| 2017 |
Dong J, Aulestia F, Kahn SA, Zeniou M, Dubois LG, El-Habr EA, Daubeuf F, Tounsi N, Cheshier SH, Frossard N, Junier MP, Chneiweiss H, Néant I, Moreau M, Leclerc C, et al. Bisacodyl and its cytotoxic activity on human glioblastoma stem-like cells. Implication of inositol 1,4,5-triphosphate receptor dependent calcium signaling. Biochimica Et Biophysica Acta. PMID 28109792 DOI: 10.1016/J.Bbamcr.2017.01.010 |
0.836 |
|
| 2017 |
Zhu H, Leiss L, Yang N, Rygh CB, Mitra SS, Cheshier SH, Weissman IL, Huang B, Miletic H, Bjerkvig R, Enger PØ, Li X, Wang J. Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy. Oncotarget. PMID 28076333 DOI: 10.18632/Oncotarget.14553 |
0.699 |
|
| 2017 |
Chow K(, Heitzeneder S, Xu P, Theruvath J, Mitra SS, Cheshier SH, Li G, Mackall C. 327 B7-H3 Chimeric Antigen Receptor Modified T Cells Show Potent Anti-Tumor Activity in a Preclinical Model of Glioblastoma Neurosurgery. 64: 272-272. DOI: 10.1093/Neuros/Nyx417.327 |
0.56 |
|
| 2017 |
Hutter G, Theruvath J, Graef CM, Weissman I, Mitra SS, Cheshier SH. TMIC-04. A POTENT MICROGLIAL RESPONSE TO BLOCKING THE CD47-SIRPα ANTI-PHAGOCYTIC AXIS OVERCOMES DEFICIENT MACROPHAGE RECRUITMENT DURING ANTI-CD47 IMMUNOTHERAPY AGAINST GLIOBLASTOMA Neuro-Oncology. 19: vi243-vi244. DOI: 10.1093/Neuonc/Nox168.994 |
0.642 |
|
| 2017 |
Theruvath J, Heitzeneder S, Majzner R, Cui K, Nellan A, Graef CM, Cheshier SH, Mackall C, Mitra SS. IMMU-45. CHECKPOINT MOLECULE B7-H3 IS HIGHLY EXPRESSED ON MEDULLOBLASTOMA AND PROVES TO BE A PROMISING CANDIDATE FOR CAR T CELL IMMUNOTHERAPY Neuro-Oncology. 19: vi122-vi122. DOI: 10.1093/Neuonc/Nox168.503 |
0.474 |
|
| 2017 |
Gholamin S, Esparza R, Cheshier S, Mitra S. TRTH-32. COMBINATION IMMUNOTHERAPY TO ACTIVATE THE INNATE IMMUNE MICROENVIRONMENT AGAINST PEDIATRIC BRAIN TUMORS Neuro-Oncology. 19: iv58-iv59. DOI: 10.1093/Neuonc/Nox083.242 |
0.803 |
|
| 2017 |
Gholamin S, Kahn S, Esparza R, Weissman I, Mitra S, Cheshier S. IMMU-18. HUMANIZED ANTI-CD47 ANTIBODY COMBINED WITH AN AGONIST ANTI-CD40 ANTIBODY IS AN EFFECTIVE TREATMENT FOR DIPG XENOGRAFTS WITH CRANIOSPINAL DISSEMINATION Neuro-Oncology. 19: iv31-iv31. DOI: 10.1093/Neuonc/Nox083.128 |
0.814 |
|
| 2017 |
Hutter G, Theruvath JL, Kahn SA, Graef CM, Schoen MK, Gholamin S, Manz EM, Weissman IL, Mitra SS, Cheshier SH. OS01.4 Induction of differential macrophage and microglial glioblastoma phagocytosis by anti CD47 treatment - implication of tumor subtypes Neuro-Oncology. 19: iii1-iii2. DOI: 10.1093/Neuonc/Nox036.003 |
0.806 |
|
| 2016 |
Assad Kahn S, Costa SL, Gholamin S, Nitta RT, Dubois LG, Fève M, Zeniou M, Coelho PL, El-Habr E, Cadusseau J, Varlet P, Mitra SS, Devaux B, Kilhoffer MC, Cheshier SH, et al. The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ-dependent inhibition of the AKT pathway. Embo Molecular Medicine. 8: 511-526. PMID 27138566 DOI: 10.15252/Emmm.201505421 |
0.797 |
|
| 2016 |
Zhang M, Hutter G, Kahn SA, Azad TD, Gholamin S, Xu CY, Liu J, Achrol AS, Richard C, Sommerkamp P, Schoen MK, McCracken MN, Majeti R, Weissman I, Mitra SS, ... Cheshier SH, et al. Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo. Plos One. 11: e0153550. PMID 27092773 DOI: 10.1371/Journal.Pone.0153550 |
0.777 |
|
| 2016 |
Rennert RC, Achrol AS, Januszyk M, Kahn SA, Liu TT, Liu Y, Sahoo D, Rodrigues M, Maan ZN, Wong VW, Cheshier SH, Chang SD, Steinberg GK, Harsh GR, Gurtner GC. Multiple subsets of brain tumor initiating cells co-exist in glioblastoma. Stem Cells (Dayton, Ohio). PMID 26991945 DOI: 10.1002/Stem.2359 |
0.833 |
|
| 2016 |
Lowe S, Eskandari R, McDonald DG, Bredlau A, Vanek KN, Banik NL, Jenrette JM, Cheshier S, Das A. IMST-18. LOW-DOSE RADIATION ALTERS ONCOGENE LEVELS AND ENHANCES T-CELL IMMUNE RECOGNITION IN HUMAN MEDULLOBLASTOMA CELLS Neuro-Oncology. 18: vi89-vi90. DOI: 10.1093/Neuonc/Now212.374 |
0.307 |
|
| 2016 |
Bredlau A, Eskandari R, McDonald DG, Lowe S, Vanek KN, Banik NL, Jenrette JM, Cheshier S, Das A. IMST-17. PHENOTYPE MODULATION OF TUMOR ASSOCIATED MICROGLIA ENHANCES PEDIATRIC MEDULLOBLASTOMA CELL DEATH IN VITRO Neuro-Oncology. 18: vi89-vi89. DOI: 10.1093/Neuonc/Now212.373 |
0.434 |
|
| 2016 |
Kahn SA, Wang X, Nitta R, Gholamin S, Ramaswamy V, Azad T, Sahoo D, Esparza R, Chu P, Fisher P, Vogel H, Li G, Cho Y, Taylor M, Mitra S, ... ... Cheshier S, et al. MB-16NOTCH1 PROMOTES GROUP 3 MEDULLOBLASTOMA METASTASIS, INITIATION AND SELF-RENEWAL Neuro-Oncology. 18: iii100.1-iii100. DOI: 10.1093/Neuonc/Now076.14 |
0.757 |
|
| 2016 |
Mitra S, Gholamin S, Feroze A, Weissman I, Cheshier S. HG-98IDENTIFICATION OF THE PRE-MALIGNANT CELL OF ORIGIN IN PEDIATRIC GLIOBLASTOMA MULTIFORME Neuro-Oncology. 18: iii71.2-iii71. DOI: 10.1093/Neuonc/Now073.94 |
0.8 |
|
| 2015 |
Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, Vogel H, Steinberg GK, Edwards MS, Li G, Duncan JA, Cheshier SH, Shuer LM, Chang EF, Grant GA, et al. Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse. Neuron. PMID 26687838 DOI: 10.1016/J.Neuron.2015.11.013 |
0.346 |
|
| 2015 |
Mitra SS, Feroze AH, Gholamin S, Richard C, Esparza R, Zhang M, Azad TD, Alrfaei B, Kahn SA, Hutter G, Guzman R, Creasey GH, Plant GW, Weissman IL, Edwards MS, ... Cheshier S, et al. Neural Placode Tissue Derived From Myelomeningocele Repair Serves as a Viable Source of Oligodendrocyte Progenitor Cells. Neurosurgery. PMID 26225855 DOI: 10.1227/Neu.0000000000000918 |
0.772 |
|
| 2015 |
Esparza R, Azad TD, Feroze AH, Mitra SS, Cheshier SH. Glioblastoma stem cells and stem cell-targeting immunotherapies. Journal of Neuro-Oncology. 123: 449-57. PMID 25682090 DOI: 10.1007/S11060-015-1729-X |
0.592 |
|
| 2015 |
Feng M, Chen JY, Weissman-Tsukamoto R, Volkmer JP, Ho PY, McKenna KM, Cheshier S, Zhang M, Guo N, Gip P, Mitra SS, Weissman IL. Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk. Proceedings of the National Academy of Sciences of the United States of America. 112: 2145-50. PMID 25646432 DOI: 10.1073/Pnas.1424907112 |
0.814 |
|
| 2015 |
Nitta RT, Gholamin S, Feroze AH, Agarwal M, Cheshier SH, Mitra SS, Li G. Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway. Oncogene. 34: 3688-99. PMID 25241897 DOI: 10.1038/Onc.2014.299 |
0.835 |
|
| 2015 |
Mitra SS, Gholamin S, Sinha R, Morganti RM, Weissman I, Cheshier SH. Abstract A11: Identification of the premalignant cell of origin in human glioblastoma multiforme Brain. 75. DOI: 10.1158/1538-7445.Brain15-A11 |
0.837 |
|
| 2015 |
Zhu H, Yang N, Leiss L, Rygh CB, Mitra SS, Cheshier SH, Huang B, Bjerkvig R, Enger PØ, Weissman IL, Li X, Wang J. Abstract 1331: Targeting CD47 triggers macrophage-dependent brain tumor destruction in a clinical relevant model Cancer Research. 75: 1331-1331. DOI: 10.1158/1538-7445.Am2015-1331 |
0.717 |
|
| 2015 |
Gholamin S, Mitra S, Esparza R, Liu J, Feroze A, Cho YJ, Zhang M, Vogel H, Edwards M, Weissman I, Cheshier S. IMPS-26HARNESSING THE MYELOID CHECKPOINT CD47-SIRPa AXIS AGAINST ADULT AND PEDIATRIC MALIGNANT BRAIN TUMORS: A NOVEL IMMUNOTHERAPEUTIC MODALITY Neuro-Oncology. 17: v118.4-v118. DOI: 10.1093/Neuonc/Nov217.25 |
0.829 |
|
| 2015 |
Kahn S, Nitta R, Wang K, Gholamin S, Azad T, Zhang M, Cho Y, Taylor M, Mitra S, Weissman I, Cheshier S. MB-01 * NOTCH1 PROMOTES MYC MEDULLOBLASTOMA METASTASIS, INITIATION AND MAINTENANCE Neuro-Oncology. 17: iii19-iii20. DOI: 10.1093/Neuonc/Nov061.77 |
0.818 |
|
| 2015 |
Gholamin S, Kahn SA, Esparza R, Hutter G, Feroze A, Weissman IL, Mitra SS, Cheshier SH. PM-08 * A HUMANIZED CO-TRANSPLANT XENOGRAFT MOUSE MODEL, TO STUDY TOXICITY OF DRUGS TARGETED AGAINST PEDIATRIC BRAIN TUMORS Neuro-Oncology. 17: iii32-iii32. DOI: 10.1093/Neuonc/Nov061.130 |
0.809 |
|
| 2014 |
Ackerman SE, Wilson CM, Kahn SA, Kintzing JR, Jindal DA, Cheshier SH, Grant GA, Cochran JR. A Bioengineered Peptide that Localizes to and Illuminates Medulloblastoma: A New Tool with Potential for Fluorescence-Guided Surgical Resection. Cureus. 6. PMID 28729960 DOI: 10.7759/Cureus.207 |
0.807 |
|
| 2014 |
Tang Y, Gholamin S, Schubert S, Willardson MI, Lee A, Bandopadhayay P, Bergthold G, Masoud S, Nguyen B, Vue N, Balansay B, Yu F, Oh S, Woo P, Chen S, ... ... Cheshier SH, et al. Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nature Medicine. 20: 732-40. PMID 24973920 DOI: 10.1038/Nm.3613 |
0.799 |
|
| 2014 |
Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S, Schumacher SE, Zeid R, Masoud S, Yu F, Vue N, Gibson WJ, Paolella BR, Mitra SS, ... Cheshier SH, et al. BET bromodomain inhibition of MYC-amplified medulloblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 912-25. PMID 24297863 DOI: 10.1158/1078-0432.Ccr-13-2281 |
0.792 |
|
| 2014 |
Perreault S, Lober RM, Cheshier S, Partap S, Edwards MS, Yeom KW. Time-dependent structural changes of the dentatothalamic pathway in children treated for posterior fossa tumor. Ajnr. American Journal of Neuroradiology. 35: 803-7. PMID 24052507 DOI: 10.3174/Ajnr.A3735 |
0.34 |
|
| 2014 |
Mitra SS, Gholamin S, Volkmer J, Feroze A, Liu J, Achrol A, Wang L, Sayles L, Zhang M, Sakamoto K, Monje-Deisseroth M, Cho Y, Sweet-Cordero A, Majeti R, Cheshier S, et al. Abstract PR12: Overcoming immune evasion in pediatric hematologic and solid tumor malignancies: A preclinical study using a humanized anti-CD47 antibody Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-Pr12 |
0.839 |
|
| 2014 |
Feroze AH, Lee K, Gholamin S, Wu Z, Weissman I, Lu B, Mitra SS, Cheshier S. Abstract LB-207: mTORC2/Akt signaling is modulated by noncanonical mitochondrial Notch1/PINK1 interaction in myc-amplified medulloblastoma tumorigenesis Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-207 |
0.82 |
|
| 2014 |
Kahn SA, Gholamin S, Zhang M, Nitta R, Weissman I, Mitra S, Cheshier S. Abstract 4041: Involvement of Notch1 signaling pathway in medulloblastoma metastasis Cancer Research. 74: 4041-4041. DOI: 10.1158/1538-7445.Am2014-4041 |
0.818 |
|
| 2014 |
Feroze A, Lee K, Alrfaei B, Gholamin S, Azad T, Mitra S, Lu B, Cheshier S. CS-07 * mTORC2/Akt SIGNALING IS MODULATED BY NONCANONICAL MITOCHONDRIAL NOTCH-PINK1 INTERACTION IN MEDULLOBLASTOMA (GROUP III) TUMORIGENESIS Neuro-Oncology. 16: v52-v52. DOI: 10.1093/Neuonc/Nou242.7 |
0.802 |
|
| 2014 |
Cho Y, Tang Y, Schubert S, Willardson M, Bandopadhayay P, Bergthold G, Nguyen B, Masoud S, Vue N, Balansay B, Gholamin S, Cheshier SH, Atwood SX, Whitson RJ, Lee A, et al. EPIGENETIC TARGETING OF HEDGEHOG PATHWAY TRANSCRIPTIONAL OUTPUT Neuro-Oncology. 16: iii25-iii25. DOI: 10.1093/Neuonc/Nou208.9 |
0.803 |
|
| 2013 |
Lee KS, Wu Z, Song Y, Mitra SS, Feroze AH, Cheshier SH, Lu B. Roles of PINK1, mTORC2, and mitochondria in preserving brain tumor-forming stem cells in a noncanonical Notch signaling pathway. Genes & Development. 27: 2642-7. PMID 24352421 DOI: 10.1101/Gad.225169.113 |
0.547 |
|
| 2013 |
Adorno M, Sikandar S, Mitra SS, Kuo A, Nicolis Di Robilant B, Haro-Acosta V, Ouadah Y, Quarta M, Rodriguez J, Qian D, Reddy VM, Cheshier S, Garner CC, Clarke MF. Usp16 contributes to somatic stem-cell defects in Down's syndrome. Nature. 501: 380-4. PMID 24025767 DOI: 10.1038/nature12530 |
0.451 |
|
| 2013 |
Higgins DM, Wang R, Milligan B, Schroeder M, Carlson B, Pokorny J, Cheshier SH, Meyer FB, Weissman IL, Sarkaria JN, Henley JR. Brain tumor stem cell multipotency correlates with nanog expression and extent of passaging in human glioblastoma xenografts. Oncotarget. 4: 792-801. PMID 23801022 DOI: 10.18632/Oncotarget.1059 |
0.641 |
|
| 2013 |
Gholamin S, Feroze AH, Mitra SS, Kahn SA, Cheshier SH. Establishment of Stereotactic Orthotopic Brain Tumor Xenografts in Mice: Technical Report Cureus. DOI: 10.7759/Cureus.150 |
0.794 |
|
| 2013 |
Gholamin S, Mitra SS, Richard CE, Achrol A, Kong D, Shin JJ, Monje-Deisseroth M, Cho Y, Weissman I, Cheshier SH. Abstract 5218: Development of Anti-CD47 therapy for pediatric brain tumors. Cancer Research. 73: 5218-5218. DOI: 10.1158/1538-7445.Am2013-5218 |
0.832 |
|
| 2013 |
Mitra SS, Gholamin S, Feroze A, Cheshier SH, Weissman IL. Abstract 5007: Delineating human fetal CNS stem cell hierarchy reveals a progenitor cell of origin for human Gliobastoma Multiforme. Cancer Research. 73: 5007-5007. DOI: 10.1158/1538-7445.Am2013-5007 |
0.838 |
|
| 2013 |
Adachi K, Sasaki H, Nagahisa S, Yoshida K, Hattori N, Nishiyama Y, Kawase T, Hasegawa M, Abe M, Hirose Y, Alentorn A, Marie Y, Poggioli S, Alshehhi H, Boisselier B, ... ... Cheshier S, ... ... Cheshier S, ... ... Cheshier S, et al. OMICS AND PROGNSTIC MARKERS Neuro-Oncology. 15: iii136-iii155. DOI: 10.1093/Neuonc/Not183 |
0.757 |
|
| 2013 |
Campian J, Gladstone D, Ambady P, Ye X, King K, Borrello I, Petrik S, Golightly M, Holdhoff M, Grossman S, Bhardwaj R, Chakravadhanula M, Ozols V, Georges J, Carlson E, ... ... Cheshier SH, et al. IMMUNOTHERAPY/BIOLOGICAL THERAPIES Neuro-Oncology. 15: iii68-iii74. DOI: 10.1093/Neuonc/Not178 |
0.743 |
|
| 2013 |
Agarwal M, Nitta R, Dovat S, Li G, Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, ... ... Cheshier S, et al. CELL BIOLOGY AND SIGNALING Neuro-Oncology. 15: iii12-iii31. DOI: 10.1093/Neuonc/Not174 |
0.773 |
|
| 2009 |
Cheshier SH, Kalani MYS, Lim M, Ailles L, Huhn SL, Weissman IL. A neurosurgeon's guide to stem cells, cancer stem cells, and brain tumor stem cells Neurosurgery. 65: 237-249. PMID 19625901 DOI: 10.1227/01.Neu.0000349921.14519.2A |
0.61 |
|
| 2008 |
Kalani MY, Cheshier SH, Cord BJ, Bababeygy SR, Vogel H, Weissman IL, Palmer TD, Nusse R. Wnt-mediated self-renewal of neural stem/progenitor cells. Proceedings of the National Academy of Sciences of the United States of America. 105: 16970-5. PMID 18957545 DOI: 10.1073/Pnas.0808616105 |
0.61 |
|
| 2008 |
Lee M, Kalani MY, Cheshier S, Gibbs IC, Adler JR, Chang SD. Radiation therapy and CyberKnife radiosurgery in the management of craniopharyngiomas. Neurosurgical Focus. 24: E4. PMID 18447743 DOI: 10.3171/Foc/2008/24/5/E4 |
0.373 |
|
| 2008 |
Guzman R, De Los Angeles A, Cheshier S, Choi R, Hoang S, Liauw J, Schaar B, Steinberg G. Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke. 39: 1300-6. PMID 18309158 DOI: 10.1161/Strokeaha.107.500470 |
0.332 |
|
| 2008 |
Bababeygy SR, Cheshier SH, Hou LC, Higgins DM, Weissman IL, Tse VC. Hematopoietic stem cell-derived pericytic cells in brain tumor angio-architecture. Stem Cells and Development. 17: 11-8. PMID 18240955 DOI: 10.1089/Scd.2007.0117 |
0.662 |
|
| 2007 |
Cheshier SH, Prohaska SS, Weissman IL. The effect of bleeding on hematopoietic stem cell cycling and self-renewal Stem Cells and Development. 16: 707-717. PMID 17999593 DOI: 10.1089/Scd.2007.0017 |
0.59 |
|
| 2006 |
Lim M, Cheshier S, Steinberg GK. New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya. Current Neurovascular Research. 3: 237-45. PMID 16918387 DOI: 10.2174/156720206778018730 |
0.317 |
|
| 2006 |
Santarelli JG, Udani V, Yung YC, Cheshier S, Wagers A, Brekken RA, Weissman I, Tse V. Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium of tumor vessels in the mouse brain. Neurosurgery. 59: 374-82; discussion 3. PMID 16883178 DOI: 10.1227/01.Neu.0000222658.66878.Cc |
0.718 |
|
| 2006 |
Tataria M, Kuscuoglu U, Lauire A, Cheshier S, Nusse R, Weissman I, Karl S. Highly enriched mesenchymal stem cells (MSC) can initiate sarcoma formation in vivo Journal of the American College of Surgeons. 203: S39-S40. DOI: 10.1016/J.Jamcollsurg.2006.05.100 |
0.577 |
|
| 2005 |
Udani V, Santarelli J, Yung Y, Cheshier S, Andrews A, Kasad Z, Tse V. Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone marrow-derived endothelial precursor cells into brain tumors Neurological Research. 27: 801-806. PMID 16354539 DOI: 10.1179/016164105X49319 |
0.476 |
|
| 2005 |
Udani VM, Santarelli JG, Yung YC, Wagers AJ, Cheshier SH, Weissman IL, Tse V. Hematopoietic stem cells give rise to perivascular endothelial-like cells during brain tumor angiogenesis. Stem Cells and Development. 14: 478-86. PMID 16305333 DOI: 10.1089/Scd.2005.14.478 |
0.752 |
|
| 2005 |
Huhn SL, Yung Y, Cheshier S, Harsh G, Ailles L, Weissman I, Vogel H, Tse V. Identification of phenotypic neural stem cells in a pediatric astroblastoma. Journal of Neurosurgery. 103: 446-50. PMID 16302618 DOI: 10.3171/Ped.2005.103.5.0446 |
0.593 |
|
| 2005 |
Cheshier S, Ailles LE, Lim M, Laddis P, Tse VC, Weissman I, Huhn SL. Flow Cytometric Analysis of Neural Stem Cell Markers on Pediatric Brain Tumors Neurosurgery. 57: 434-434. DOI: 10.1093/Neurosurgery/57.2.434A |
0.627 |
|
| 2004 |
Yung YC, Cheshier S, Santarelli JG, Huang Z, Wagers A, Weissman I, Tse V. Incorporation of naive bone marrow derived cells into the vascular architecture of brain tumor. Microcirculation (New York, N.Y. : 1994). 11: 699-708. PMID 15726837 DOI: 10.1080/10739680490521005 |
0.73 |
|
| 2002 |
Allsopp RC, Cheshier S, Weissman IL. Telomerase activation and rejuvenation of telomere length in stimulated T cells derived from serially transplanted hematopoietic stem cells. The Journal of Experimental Medicine. 196: 1427-33. PMID 12461078 DOI: 10.1084/Jem.20021003 |
0.576 |
|
| 2001 |
Allsopp RC, Cheshier S, Weissman IL. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. The Journal of Experimental Medicine. 193: 917-24. PMID 11304552 DOI: 10.1084/Jem.193.8.917 |
0.535 |
|
| 2001 |
Wright DE, Cheshier SH, Wagers AJ, Randall TD, Christensen JL, Weissman IL. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood. 97: 2278-85. PMID 11290588 DOI: 10.1182/Blood.V97.8.2278 |
0.784 |
|
| 2000 |
Klug CA, Cheshier S, Weissman IL. Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny Blood. 96: 894-901. PMID 10910902 DOI: 10.1182/Blood.V96.3.894.015K35_894_901 |
0.712 |
|
| 2000 |
Domen J, Cheshier SH, Weissman IL. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. The Journal of Experimental Medicine. 191: 253-64. PMID 10637270 DOI: 10.1084/Jem.191.2.253 |
0.577 |
|
| 2000 |
Klug CA, Cheshier S, Weissman IL. Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny Blood. 96: 894-901. DOI: 10.1182/BLOOD.V96.3.894.015K35_894_901 |
0.518 |
|
| 1999 |
Akashi K, Kondo M, Cheshier S, Shizuru J, Gandy K, Domen J, Mebius R, Traver D, Weissman IL. Lymphoid development from stem cells and the common lymphocyte progenitors. Cold Spring Harbor Symposia On Quantitative Biology. 64: 1-12. PMID 11232274 DOI: 10.1101/Sqb.1999.64.1 |
0.754 |
|
| 1999 |
Cheshier SH, Morrison SJ, Liao X, Weissman IL. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 96: 3120-5. PMID 10077647 DOI: 10.1073/Pnas.96.6.3120 |
0.666 |
|
| 1997 |
Morrison SJ, Wright DE, Cheshier SH, Weissman IL. Hematopoietic stem cells: challenges to expectations. Current Opinion in Immunology. 9: 216-21. PMID 9099790 DOI: 10.1016/S0952-7915(97)80138-0 |
0.75 |
|
| 1995 |
Casillas AM, Thompson AD, Cheshier S, Hernandez S, Aguilera RJ. RAG-1 and RAG-2 gene expression and V(D)J recombinase activity are enhanced by protein phosphatase 1 and 2A inhibition in lymphocyte cell lines. Molecular Immunology. 32: 167-75. PMID 7898493 DOI: 10.1016/0161-5890(94)00142-N |
0.337 |
|
| Show low-probability matches. |
